IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha. - Wikidata - awgldk - TriplyDB

IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha.

IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha.

http://www.wikidata.org/entity/Q37485142

about

Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer Combining theoretical analysis and experimental data generation reveals IRF9 as a crucial factor for accelerating interferon α-induced early antiviral signalling.Antiproliferative Properties of Type I and Type II Interferon.Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophages.Identification of alpha interferon-induced genes associated with antiviral activity in Daudi cells and characterization of IFIT3 as a novel antiviral gene.Near eradication of clinically relevant concentrations of human tumor cells by interferon-activated monocytes in vitro.The functional consequences of variation in transcription factor binding.A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis.DNA methylation transcriptionally regulates the putative tumor cell growth suppressor ZNF677 in non-small cell lung cancers BID is a critical factor controlling cell viability regulated by IFN-α.Apoptosis-inducing factor (AIF) is targeted in IFN-α2a-induced Bid-mediated apoptosis through Bak activation in ovarian cancer cells.A novel role for IFN-stimulated gene factor 3II in IFN-γ signaling and induction of antiviral activity in human cells.Plasmacytoid dendritic cells in the tumor microenvironment: immune targets for glioma therapeutics.Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication.Immunomodulatory effects of interferons in malignancies.Apoptosis and other immune biomarkers predict influenza vaccine responsiveness.Chronic Heat Stress Induces Immune Response, Oxidative Stress Response, and Apoptosis of Finishing Pig Liver: A Proteomic Approach.IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα2 through IRF9.TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2.2.15 cells by activating the JAK-STAT signaling pathway.Sensitization of glycoengineered interferon-β1a-resistant cancer cells by cFLIP inhibition for enhanced anti-cancer therapy.Reciprocal inhibition between intracellular antiviral signaling and the RNAi machinery in mammalian cells Identification of biomarkers for pseudo and true progression of GBM based on radiogenomics study Analysis of differentiation potentials and gene expression profiles of mesenchymal stem cells derived from periodontal ligament and Wharton's jelly of the umbilical cord.OSMR gene effect on the pathogenesis of chronic autoimmune Urticaria via the JAK/STAT3 pathway.

P2860

Q24202094-8CC079E0-C10E-42E2-A913-1909377A45A0 Q24203808-770F052F-66AE-41CA-9F03-AE687A031A92 Q33724668-373A675C-1211-432D-8812-7BE3F6676803 Q34007700-691173D1-51BC-47E7-B9BB-5550809E7705 Q34025307-55EE2FB2-91FD-4AEC-8A1E-038317113539 Q34178274-8EEAF5CC-DAA7-4DC3-ACE1-EC0A715B8E71 Q35084138-B8C41725-56F5-4283-9805-D404678BA1BC Q35112922-2048D858-5581-4C22-B195-13CD66709797 Q35174510-9B0F5BA5-C4F4-4542-8367-040F8F748F2E Q35238487-320EDC35-29AC-417B-A833-B18ED8359BBF Q35621716-5E77AAE0-2525-4CFE-B74A-3A6D35FB9FB6 Q36074708-73E2D2D3-EA6F-4CBC-B35F-6B589845CAFD Q36158559-6546C0FF-DEC4-485F-952E-C2F413CEF546 Q36200438-414F14BC-F0CE-437C-9F8D-E5AF698AEDF5 Q36730005-ECE267B3-91A3-4A4F-A787-8B8978E3A056 Q36825411-7139599E-CC5F-4E85-8E16-7C278F9DCE99 Q36856669-1FBCB849-A5E6-4878-AB88-770ED3AA5ED2 Q36939025-F7057D57-D85E-44C3-A1CC-861D2D89918C Q37120262-C569C878-854A-4818-84B0-85C8921DAE11 Q37482744-D7965FFE-18F8-4556-8DF8-894CEA5707B8 Q37706731-D627F60D-BF2A-4E8B-8952-1F35D2BE5C3F Q39090397-235E6C38-39A6-40C8-9E93-53294FE29697 Q39598112-334C3BE1-CBD7-4411-901A-6BDBBA1F8F4D Q44005266-3C47A22C-3B49-4154-A041-CF215C62512D Q55421591-181C935D-135B-4249-9A0B-4EAEF921D7F5

P2860

IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha.

http://www.wikidata.org/entity/Q37485142

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha.

@en

IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha.

@nl

type

label

IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha.

@en

IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha.

@nl

prefLabel

IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha.

@en

IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha.

@nl

P1433

Q37485142-2C32F1C7-6AC8-4DA1-BF48-B71CED0F48BF

P1476

Q37485142-C79441F1-3DEA-4D31-B47A-11B0D62F7343

P2093

Q37485142-2F5D146A-76F8-4764-AF9C-E0846407B2A1

Q37485142-31260593-3AA2-48BE-B375-82197FE75AD8

Q37485142-4B43D335-C07C-4E25-AF01-E9291C6A4F7E

Q37485142-52A4567A-6222-47EE-AD19-1CEC687AC87E

Q37485142-9B4DE399-3744-4AD2-8282-28114B0DEFFE

Q37485142-DFBAD559-48A4-4D9B-B88D-1686188E0F9A

P2860

Q37485142-16770D7B-2CE1-4E83-9943-AAA8B45080C1

Q37485142-1ADD8A52-874B-4BD8-B006-348118F52F46

Q37485142-1B5E1453-A4AC-44A0-960D-297A3327A03D

Q37485142-1FEC16C9-23BB-446D-B674-38366EAE5DB0

Q37485142-24953AE8-2606-4573-91D0-475435B1FC60

Q37485142-27D9E183-E743-4ECC-802E-4E43CF1C9810

Q37485142-28C6CC43-1DBE-446C-8C61-C501BCB338C4

Q37485142-2B7818EF-15ED-4F1D-86A0-1909434D206F

Q37485142-40A2E37D-6FF7-4469-9B0B-F34FBAC03815

Q37485142-4E1A80FD-FE8A-411E-B0BA-F5CD88344D33

P304

Q37485142-BDD17733-FEBC-4E4D-A988-6BD20A396801

P31

Q37485142-1A90FC52-5FD5-4D89-9096-35BEC20FFDA1

P356

Q37485142-B939A6CA-B131-453F-8A59-F282E961AD4E

P433

Q37485142-9A7E2B23-DD65-473F-8D52-AD65A20C8393

P478

Q37485142-6CCBCA56-7458-4E8E-B0E7-3E2D0EB96B3F

P577

Q37485142-61C739F0-85B9-4C42-BC7E-E0DF94107118

P698

Q37485142-E0580BBE-153D-4F77-A63A-DF7227F8E0CB

P932

Q37485142-D30DB2C7-F1EE-4F7A-BD63-0029937C50E8

P356

CJI.0B013E3181AD4092

P1433

Journal of Immunotherapy

P1476

IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha.

@en

P2093

Angel Morrow

http://www.w3.org/2001/XMLSchema#string

Hana Schmeisser

http://www.w3.org/2001/XMLSchema#string

Josef Mejido

http://www.w3.org/2001/XMLSchema#string

Kathryn C Zoon

http://www.w3.org/2001/XMLSchema#string

Takaya Tsuno

http://www.w3.org/2001/XMLSchema#string

Tongmao Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of two receptors for TRAIL

The receptor for the cytotoxic ligand TRAIL

Diverse transcriptional initiation revealed by fine, large-scale mapping of mRNA start sites

Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes

Gene Expression Profiling of the Cellular Transcriptional Network Regulated by Alpha/Beta Interferon and Its Partial Attenuation by the Hepatitis C Virus Nonstructural 5A Protein

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

Primer3 on the WWW for general users and for biologist programmers

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

Signaling through the JAK/STAT pathway, recent advances and future challenges

Resistance to interferons in melanoma cells does not correlate with the expression or activation of signal transducer and activator of transcription 1 (Stat1)

P304

803-816

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/CJI.0B013E3181AD4092

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19752753

http://www.w3.org/2001/XMLSchema#string

P932

2796296

http://www.w3.org/2001/XMLSchema#string